X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23863) 23863
Publication (2937) 2937
Book Review (441) 441
Book Chapter (211) 211
Book / eBook (183) 183
Conference Proceeding (42) 42
Dissertation (38) 38
Magazine Article (10) 10
Newsletter (8) 8
Data Set (7) 7
Government Document (7) 7
Newspaper Article (7) 7
Reference (6) 6
Paper (4) 4
Web Resource (3) 3
Trade Publication Article (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14254) 14254
male (12139) 12139
animals (12093) 12093
index medicus (11912) 11912
female (7373) 7373
androgen receptor (4656) 4656
mice (4455) 4455
endocrinology & metabolism (4279) 4279
oncology (4246) 4246
rats (4112) 4112
prostate cancer (3799) 3799
receptors, androgen - metabolism (3501) 3501
cell line, tumor (3493) 3493
expression (3489) 3489
cancer (3236) 3236
research (2834) 2834
androgens (2686) 2686
gene expression (2630) 2630
testosterone (2596) 2596
biochemistry & molecular biology (2478) 2478
prostatic neoplasms - pathology (2396) 2396
apoptosis (2330) 2330
cell biology (2289) 2289
estrogen (2265) 2265
prostatic neoplasms - metabolism (2151) 2151
receptor (2053) 2053
prostatic neoplasms - drug therapy (1969) 1969
receptors, androgen - genetics (1962) 1962
proteins (1961) 1961
article (1959) 1959
gene-expression (1935) 1935
pharmacology & pharmacy (1915) 1915
signal transduction (1914) 1914
research article (1810) 1810
medicine (1795) 1795
cell proliferation - drug effects (1746) 1746
health aspects (1731) 1731
receptors (1700) 1700
physiological aspects (1698) 1698
multidisciplinary sciences (1681) 1681
testosterone - pharmacology (1656) 1656
dose-response relationship, drug (1625) 1625
middle aged (1605) 1605
genetic aspects (1580) 1580
breast cancer (1578) 1578
signal transduction - drug effects (1563) 1563
androgens - pharmacology (1554) 1554
prostate (1531) 1531
growth (1491) 1491
care and treatment (1486) 1486
analysis (1474) 1474
adult (1446) 1446
activation (1432) 1432
cells, cultured (1424) 1424
tumors (1405) 1405
estradiol - pharmacology (1395) 1395
cells (1385) 1385
in-vitro (1385) 1385
toxicology (1381) 1381
apoptosis - drug effects (1368) 1368
rats, sprague-dawley (1305) 1305
urology & nephrology (1289) 1289
science (1286) 1286
aged (1283) 1283
prostatic neoplasms - genetics (1270) 1270
biology (1256) 1256
neurosciences (1241) 1241
tumor cells, cultured (1217) 1217
metastasis (1216) 1216
kinases (1211) 1211
dihydrotestosterone - pharmacology (1175) 1175
hormones (1175) 1175
receptors, androgen - drug effects (1172) 1172
immunohistochemistry (1169) 1169
rodents (1163) 1163
ligands (1162) 1162
review (1160) 1160
antineoplastic agents - pharmacology (1154) 1154
breast-cancer (1129) 1129
cell line (1112) 1112
cell proliferation (1102) 1102
rna, messenger - metabolism (1099) 1099
phosphorylation (1093) 1093
androgen antagonists - pharmacology (1086) 1086
androgen (1079) 1079
development and progression (1058) 1058
physiology (1056) 1056
genes (1040) 1040
estradiol (1023) 1023
estrogen-receptor (1014) 1014
proliferation (998) 998
receptors, estrogen - metabolism (979) 979
metabolism (965) 965
prostate-cancer (961) 961
reverse transcriptase polymerase chain reaction (960) 960
orchiectomy (955) 955
pregnancy (941) 941
therapy (934) 934
blotting, western (933) 933
mutation (931) 931
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (133) 133
Online Resources - Online (13) 13
UofT at Mississauga - Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
UofT at Scarborough - Stacks (5) 5
UTL at Downsview - May be requested (4) 4
St. Michael's Hospital - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23970) 23970
Japanese (73) 73
Chinese (50) 50
German (49) 49
French (46) 46
Russian (46) 46
Spanish (20) 20
Italian (13) 13
Polish (11) 11
Hungarian (5) 5
Czech (4) 4
Portuguese (3) 3
Arabic (2) 2
Dutch (2) 2
Finnish (2) 2
Korean (2) 2
Afrikaans (1) 1
Danish (1) 1
Norwegian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Cell, ISSN 1535-6108, 2011, Volume 19, Issue 5, pp. 575 - 586
Prostate cancer is characterized by its dependence on androgen receptor (AR) and frequent activation of PI3K signaling. We find that AR transcriptional output... 
TARGET | CELLS | ONCOLOGY | PATHWAY | DUAL PI3K/MTOR INHIBITOR | KINASE | TUMOR-SUPPRESSOR | AKT | INDUCTION | MTOR COMPLEX | HORMONAL-THERAPY | CELL BIOLOGY | Receptor, ErbB-3 - metabolism | Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Humans | Phosphoprotein Phosphatases - metabolism | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Male | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Prostatic Neoplasms - genetics | Receptors, Androgen - drug effects | Transfection | RNA Interference | Time Factors | Transcription, Genetic | Receptor, ErbB-2 - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - metabolism | Phosphatidylinositol 3-Kinase - metabolism | Genes, Reporter | Prostatic Neoplasms - drug therapy | PTEN Phosphohydrolase - genetics | Prostatic Neoplasms - pathology | PTEN Phosphohydrolase - deficiency | Androgen Antagonists - pharmacology | Receptor, ErbB-3 - antagonists & inhibitors | Mice, Transgenic | Nuclear Proteins - metabolism | Mice, SCID | Proto-Oncogene Proteins c-myc - metabolism | Mice, Knockout | Xenograft Model Antitumor Assays | Magnetic Resonance Imaging | Feedback, Physiological | Animals | Signal Transduction - drug effects | Tumor Burden - drug effects | Cell Line, Tumor | Prostatic Neoplasms - enzymology | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins c-myc - genetics | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Phosphatases | Health aspects | Phosphotransferases | Prostate cancer | Analysis | Tumors
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 68, Issue 2, pp. 228 - 235
Abstract Background Cabazitaxel, abiraterone acetate (AA), and enzalutamide have been approved for the treatment of patients with metastatic... 
Urology | Metastatic | Abiraterone | Prostate cancer | Cabazitaxel | ENZALUTAMIDE MDV3100 | CROSS-RESISTANCE | ANTITUMOR-ACTIVITY | CHEMOTHERAPY | PACLITAXEL | ANTIANDROGEN | UROLOGY & NEPHROLOGY | ABIRATERONE ACETATE | INCREASED SURVIVAL | RESISTANT PROSTATE-CANCER | CASTRATION-RESISTANT | Phenylthiohydantoin - adverse effects | Phenylthiohydantoin - therapeutic use | Humans | Middle Aged | Receptors, Androgen - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Molecular Targeted Therapy | Prostatic Neoplasms, Castration-Resistant - pathology | Dose-Response Relationship, Drug | Taxoids - therapeutic use | Receptors, Androgen - drug effects | Time Factors | Aged, 80 and over | Kallikreins - blood | Retrospective Studies | France | Taxoids - adverse effects | Cell Survival - drug effects | Androstenes - adverse effects | Kaplan-Meier Estimate | Androstenes - therapeutic use | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Prostatic Neoplasms, Castration-Resistant - metabolism | Phenylthiohydantoin - analogs & derivatives | Prostate-Specific Antigen - blood | Disease-Free Survival | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Androgen Antagonists - therapeutic use | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | Prostatic Neoplasms, Castration-Resistant - mortality | Androgen Antagonists - adverse effects
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 67, Issue 3, pp. 470 - 479
Journal Article
Cancer Research, ISSN 0008-5472, 03/2012, Volume 72, Issue 6, pp. 1494 - 1503
Journal Article
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 379, Issue 1, pp. 154 - 160
Journal Article